Le Cong

Le Cong


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
YQYuanhao Qu
Yuanhao Qu
KHKaixuan Huang
Kaixuan Huang
MYMing Yin
Ming Yin
KZKanghong Zhan
Kanghong Zhan
DLDyllan Liu
Dyllan Liu
LCLe Cong
Le Cong
Performing effective gene-editing experiments requires a deep understanding of both the CRISPR technology and the biological system involved. Meanwhile, despite their versatility and promise, large language models (LLMs) often lack domain-specific knowledge and struggle to accurately solve biological design problems. We present CRISPR-GPT, an LLM agent system to automate and enhance CRISPR-based gene-editing design and data analysis. CRISPR-GPT leverages the reasoning capabilities of LLMs for complex task decomposition, decision-making and interactive human–artificial intelligence (AI) collaboration. This system incorporates domain expertise, retrieval techniques, external tools and a specialized LLM fine tuned with open-forum discussions among scientists. CRISPR-GPT assists users in selecting CRISPR systems, experiment planning, designing guide RNAs, choosing delivery methods, drafting protocols, designing assays and analysing data. We showcase the potential of CRISPR-GPT by knocking out four genes with CRISPR-Cas12a in a human lung adenocarcinoma cell line and epigenetically activating two genes using CRISPR-dCas9 in a human melanoma cell line. CRISPR-GPT enables fully AI-guided gene-editing experiment design and analysis across different modalities, validating its effectiveness as an AI co-pilot in genome engineering.

10 February 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
CWChengkun Wang
Chengkun Wang
YQYuanhao Qu
Yuanhao Qu
JCJason K. W. Cheng
Jason K. W. Cheng
NHNicholas W. Hughes
Nicholas W. Hughes
QZQianhe Zhang
Qianhe Zhang
LCLe Cong
Le Cong
Gene editing is a powerful tool for genome and cell engineering. Exemplified by CRISPR–Cas, gene editing could cause DNA damage and trigger DNA repair processes that are often error-prone. Such unwanted mutations and safety concerns can be exacerbated when altering long sequences. Here we couple microbial single-strand annealing proteins (SSAPs) with catalytically inactive dCas9 for gene editing. This cleavage-free gene editor, dCas9–SSAP, promotes the knock-in of long sequences in mammalian cells. The dCas9–SSAP editor has low on-target errors and minimal off-target effects, showing higher accuracy than canonical Cas9 methods. It is effective for inserting kilobase-scale sequences, with an efficiency of up to approximately 20% and robust performance across donor designs and cell types, including human stem cells. We show that dCas9–SSAP is less sensitive to inhibition of DNA repair enzymes than Cas9 references. We further performed truncation and aptamer engineering to minimize its size to fit into a single adeno-associated-virus vector for future application. Together, this tool opens opportunities towards safer long-sequence genome engineering.
1

20 August 2026 in Science
Verified
Journal Article
Closed access
KHKexin Huang
Kexin Huang
SZSerena Zhang
Serena Zhang
HWHanchen Wang
Hanchen Wang
YQYuanhao Qu
Yuanhao Qu
YLYingzhou Lu
Yingzhou Lu
JLJure Leskovec
Jure Leskovec
Biomedical research is increasingly constrained by repetitive, fragmented workflows that slow discovery. We introduce Biomni, a general-purpose biomedical artificial intelligence agent that autonomously executes diverse research tasks. To map the biomedical action space, Biomni’s action-discovery agent mines tools, databases, and protocols from thousands of publications across 25 domains, building a unified agentic environment. Its general-purpose architecture integrates large language model reasoning with retrieval-augmented planning and code-based execution, dynamically composing workflows without predefined templates. Systematic benchmarking shows strong generalization across heterogeneous tasks—causal gene prioritization, drug repurposing, rare-disease diagnosis, microbiome analysis, and molecular cloning—without task-specific tuning. Real-world case studies demonstrate Biomni interpreting multimodal datasets, optimizing protein stability, orchestrating wet-lab instruments, and generating experimentally testable protocols. Biomni envisions artificial intelligence augmenting human scientists and accelerating discovery.

29 March 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BLBinquan Luan
Binquan Luan
GXGuangxue Xu
Guangxue Xu
MFMei Feng
Mei Feng
LCLe Cong
Le Cong
RZRuhong Zhou
Ruhong Zhou

24 June 2022 in Molecular Cell
Verified
Journal Article
Open access
NHNicholas W. Hughes
Nicholas W. Hughes
YQYuanhao Qu
Yuanhao Qu
JZJiaqi Zhang
Jiaqi Zhang
WTWeijing Tang
Weijing Tang
JPJustin Pierce
Justin Pierce
LCLe Cong
Le Cong
The development of CRISPR-based barcoding methods creates an exciting opportunity to understand cellular phylogenies. We present a compact, tunable, high-capacity Cas12a barcoding system called dual acting inverted site array (DAISY). We combined high-throughput screening and machine learning to predict and optimize the 60-bp DAISY barcode sequences. After optimization, top-performing barcodes had ∼10-fold increased capacity relative to the best random-screened designs and performed reliably across diverse cell types. DAISY barcode arrays generated ∼12 bits of entropy and ∼66,000 unique barcodes. Thus, DAISY barcodes-at a fraction of the size of Cas9 barcodes-achieved high-capacity barcoding. We coupled DAISY barcoding with single-cell RNA-seq to recover lineages and gene expression profiles from ∼47,000 human melanoma cells. A single DAISY barcode recovered up to ∼700 lineages from one parental cell. This analysis revealed heritable single-cell gene expression and potential epigenetic modulation of memory gene transcription. Overall, Cas12a DAISY barcoding is an efficient tool for investigating cell-state dynamics.

22 February 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CWChengkun Wang
Chengkun Wang
JCJason K W Cheng
Jason K W Cheng
QZQianhe Zhang
Qianhe Zhang
NHNicholas W Hughes
Nicholas W Hughes
QXQiong Xia
Qiong Xia
LCLe Cong
Le Cong
Several existing technologies enable short genomic alterations including generating indels and short nucleotide variants, however, engineering more significant genomic changes is more challenging due to reduced efficiency and precision. Here, we developed RecT Editor via Designer-Cas9-Initiated Targeting (REDIT), which leverages phage single-stranded DNA-annealing proteins (SSAP) RecT for mammalian genome engineering. Relative to Cas9-mediated homology-directed repair (HDR), REDIT yielded up to a 5-fold increase of efficiency to insert kilobase-scale exogenous sequences at defined genomic regions. We validated our REDIT approach using different formats and lengths of knock-in templates. We further demonstrated that REDIT tools using Cas9 nickase have efficient gene-editing activities and reduced off-target errors, measured using a combination of targeted sequencing, genome-wide indel, and insertion mapping assays. Our experiments inhibiting repair enzyme activities suggested that REDIT has the potential to overcome limitations of endogenous DNA repair steps. Finally, our REDIT method is applicable across cell types including human stem cells, and is generalizable to different Cas9 enzymes.